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HIV-1 replication requires transport of nascent viral
DNA and associated virion proteins, the retroviral
preintegration complex (PIC), into the nucleus. Too
large for passive diffusion through nuclear pore
complexes (NPCs), PICs use cellular nuclear trans-
port mechanisms and nucleoporins (NUPs), the
NPC components that permit selective nuclear-cyto-
plasmic exchange, but the details remain unclear.
Here we identify a fragment of the cleavage and poly-
adenylation factor 6, CPSF6, as a potent inhibitor of
HIV-1 infection. When enriched in the cytoplasm,
CPSF6 prevents HIV-1 nuclear entry by targeting the
viral capsid (CA). HIV-1 harboring the N74D mutation
in CA fails to interact with CPSF6 and evades the
nuclear import restriction. Interestingly, whereas
wild-typeHIV-1 requiresNUP153,N74DHIV-1mimics
feline immunodeficiency virus nuclear import require-
ments and is more sensitive to NUP155 depletion.
These findings reveal a remarkable flexibility in HIV-
1 nuclear transport and highlight a single residue in
CA as essential in regulating interactions with NUPs.
INTRODUCTION
The synthesis of viral DNA (vDNA) from an RNA genome
precursor and the insertion of the linear vDNA into the host cell
chromatin are defining characteristics of retroviral replication.
While the contributions of virion enzymatic proteins in reverse
transcription and integration have been elegantly elaborated,Cell Hothe interaction of retroviruses with the host cell environment
during early replication is less well understood. Progression
from reverse transcription to integration requires the transport
of amegadalton complex of nascent vDNA and associated virion
proteins, comprising the retroviral PIC, across the nuclear
membrane. PICs are presumably dependent on host cell mech-
anisms to enter the nucleus (Fassati, 2006). Gammaretroviruses,
such as murine leukemia virus (MLV), generally require progres-
sion through mitosis to integrate their genomes (Lewis and
Emerman, 1994; Roe et al., 1993) but have also been observed
to infect nonproliferating monocytes that are stimulated to differ-
entiate (Jarrosson-Wuilleme et al., 2006). Lentiviruses, in con-
trast, integrate their genomes in both dividing cells and terminally
differentiated cells, such as macrophages (Fassati, 2006).
The mechanisms exploited by lentiviruses, in particular HIV-1,
to infect nondividing cells have been a subject of debate. Lenti-
viral PICs have been proposed to enter the nucleus via nuclear
localization signal (NLS)-dependent and -independent path-
ways. A number of viral determinants, including matrix (MA),
integrase (IN), Vpr, and discontinuous, triple-stranded vDNA
present at the HIV-1 central polypurine tract have been sug-
gested to play key roles in nuclear entry (Bouyac-Bertoia et al.,
2001; Bukrinsky et al., 1993; de Noronha et al., 2001; Gallay
et al., 1995a, 1995b, 1997; Haffar et al., 2000; Heinzinger et al.,
1994; Popov et al., 1998; Zennou et al., 2000). While these
elements are either essential or can enhance the infection of
dividing and nondividing cells, their specific contributions to
nuclear entry have been questioned (Bukrinsky, 2004; Dvorin
et al., 2002; Freed et al., 1995; Freed and Martin, 1994; Limon
et al., 2002; Yamashita and Emerman, 2005, 2006).
One HIV-1 ‘‘nuclear-entry’’ determinant that has received
scrutiny is CA, which comprises the core shell of mature retro-
virus particles. CA dissociates from the HIV-1 reverse-transcrip-
tion complex (RTC) prior to nuclear entry (Fassati andGoff, 2001;st & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevier Inc. 221
Figure 1. Alignment of the Predicted Open
Reading Frames of Human CPSF6, Mouse
CPSF6, and mCPSF6-358
Human residues encoded by exon 6 are shown,
though, as indicated for mCPSF6, this stretch is
missing from the mouse 68 kD splice variant.
Exon boundaries and protein domains are de-
noted by downward triangles and shaded boxes,
respectively. Protein domains including the RNA-
recognition motif (RRM) are labeled (Ruegsegger
et al., 1998), and NLS determinants are boxed
(Dettwiler et al., 2004). Amino acids in italics are
acquired from the pMIGR1 vector and not needed
for antiviral function (data not shown).
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CPSF6 Restricts HIV-1 Nuclear EntryMcDonald et al., 2002). The mechanism by which HIV-1 sepa-
rates from its CA core before accessing the nuclear pore is
unclear, but data suggest that substantial levels of CA may
remain associated with the PIC following reverse transcription
(Arhel et al., 2007; Dismuke and Aiken, 2006). Chimeric retrovi-
ruses in which HIV-1 CA is replaced with MLV CA are unable
to infect nondividing cells (Yamashita and Emerman, 2004).
Specific point mutations in CA can also impair the ability of
HIV-1 to infect nondividing transformed cells and primary human
macrophages (Yamashita et al., 2007).
HIV-1 CAmutants impaired in the infection of nondividing cells
have a spectrum of phenotypes. For example, CA mutant Q63A/
Q67A is impaired for nuclear entry and retains elevated levels of
PIC-associatedCAprotein (DismukeandAiken, 2006).CAmutant
T54A/N57A efficiently delivers its viral genome to the nucleus of
nondividing cells but fails to integrate (Yamashita et al., 2007).
Collectively such data suggest HIV-1 core dissociation, nuclear
transport, and integration are tightly coupled processes.
The interaction of cellular factors with CA has been suggested
to regulate HIV infection of nondividing cells (Yamashita et al.,
2007). However, HIV-1 CA has not been directly associated
with nuclear import factors. Defective tRNA species can facilitate
the nuclear transport of HIV-1 RTCs in an in vitro system,
possibly serving to tether the RTC to proteins that traffic to the
nucleus (Zaitseva et al., 2006). How these tRNAs interact with
the RTC has not yet been elucidated. Another study suggested
that cyclophilin A (CypA) interactions, at least for certain CA
mutant viruses, might regulate infection of nondividing cells after
vDNA nuclear entry (Qi et al., 2008).
Genome-wide screens using RNA interference (RNAi) technol-
ogies have revealed a wealth of host factors that, when depleted
from cells, can limit HIV-1 infection (Brass et al., 2008; Ko¨nig
et al., 2008; Zhou et al., 2008). The majority of these factors
have not yet been carefully analyzed for direct interaction with
HIV-1 or its infection pathway. One exception is TNPO3, a karyo-
pherin known to transport S/R family proteins, which was identi-
fied in two functional screens to be required for HIV-1 infection at
a step after reverse transcription (Brass et al., 2008; Ko¨nig et al.,222 Cell Host & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevier Inc.2008). Subsequent work suggested that
TNPO3 facilitates the nuclear transport
of the PIC (Christ et al., 2008). Nuclear
pore-associated factors were also identi-
fied as possible HIV-1 cofactors in the
same two screens. Although it is notknown how these various NUP proteins interact with HIV-1,
infection with HIV-1 mutants that evade restrictions can be
used to identify cofactors that play a pivotal role in virus infection.
In this study, we sought to identify proteins that interfere with
the early steps of HIV-1 infection through a functional screening
approach using a cDNA expression library. We identified an S/R
family protein, cleavage and polyadenylation factor 6 (CPSF6),
that, when C-terminally truncated, potently restricts HIV-1 and
SIV infection, but not infection by other retroviruses. Cells ectop-
ically expressing CPSF6 impaired the nuclear entry of HIV-1.
A single amino acid substitution within CA bypasses this restric-
tion. This mutant virus has provided a unique tool with which we
have probed the nuclear pore requirements for HIV-1 infection
and biologically linked CA to transport through the macromolec-
ular structure.
RESULTS
C-Terminally Truncated CPSF6 Identified in a Screen
for HIV-1-Interfering Proteins
We identified cells resistant to infection with an HIV-1 vector
using a cDNA expression screen (see Figure S1 available online).
Independent clones of these cells contained a cDNA encoding a
splice variant of the 68 kDa component of cleavage factor (CF) Im
(Ruegsegger et al., 1998), also known as CPSF6 (Figure 1). The
cDNA present in the resistant cells contained an exon (exon 6
in humans) normally spliced from human and mouse mRNA
encoding the 68 kDa form of CPSF6, and the cDNA was prema-
turely truncated within the subsequent exon as a result of
random cDNA priming.
NIH 3T3.hCycT1 cells stably expressing the truncated 358
amino acid protein obtained in the screen, mCPSF6-358,
strongly restricted infection by the single-round vector HIV-
RFP/VSV-G (Figure 2A). Elevated expression of the 68 kDa
mouse CPSF6 did not impair susceptibility to the same virus,
while stable expression of full-length human CPSF6 including
exon 6, CPSF6(72), marginally impaired infection. Truncation of
mouse or human CPSF6 after residue 526, which removes the
Figure 2. C-Terminally Truncated CPSF6 Restricts HIV-1 Infection
(A) Infection of NIH 3T3.hCycT1 cells stably expressing different CPSF6 molecules by HIV-RFP/VSV-G. Error bars represent standard deviations of duplicates.
(B) (Upper panels) Subcellular localization of endogenous, ectopically expressed wild-type, and mutant CPSF6 molecules in NIH 3T3.hCycT1 cell lines that
express the mutant proteins. (Lower panels) Controls to validate cell fractionation.
(C) mCPSF6-358 blocks HIV-1 infection in primary T cells. Numbers represent percent of GFP+ cells over HSA+ cells day 4 postsuperinfection.
(D) Infection of HeLa cells expressing mCPSF6-358 with HIV-RFP/VSV-G andMX-RFP/VSV-G vectors. The percent of the cells that were infected wasmeasured
by FACS for RFP expression; the amounts of the virus containing supernatants are shown on the x axis.
(E) Replication-competent primate lentiviruses are inhibited bymCPSF6-358. Infections were performed under single-cycle conditions usingMAGI cells express-
ing CCR5. Cells that expressedmCPSF6-358 are shown by the black bars. MLV expressing HIV-1 Tat and pseudotyped with VSV-G was used as a control. Error
bars represent standard deviations of duplicate experiments.
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CPSF6 Restricts HIV-1 Nuclear EntryC-terminal arginine/serine-rich domain and elements required
for nuclear localization (Figure 1), was sufficient to enhance anti-
viral function (Figure 2A). The truncated forms of CPSF6 thatCell Horestrict HIV-1 are enriched in the cytoplasm (Figure 2B and
Figure S2A), while endogenous CPSF6 is predominantly nuclear.
Truncated CPSF6 also restricted HIV-1 in human cells.st & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevier Inc. 223
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CPSF6 Restricts HIV-1 Nuclear EntryExpression of mCPSF6-358 in primary human CD4+ T cells was
as effective as rhesus (rh) TRIM5a in rendering these cells resis-
tant to HIV-1 infection (Figure 2C).
Despite the antiviral properties of mCPSF6-358, endogenous
CPSF6 did not appear to function as a cofactor for HIV-1 infec-
tion. Depletion of cellular CPSF6 with short interfering (si) RNAs
did not impair HIV-RFP/VSV-G infection of HeLa cells
(Figure S2B) or relieve the block imposed by mCPSF6-358
(Figure S2C). A consistent increase in HIV-1 infection was
observed in control cells depleted for endogenous CPSF6 in
these and other experiments.
To understand whether stable expression of mCPSF6-358
restricts infection by other retroviruses, control and mCPSF6-
358-expressing HeLa cells were challenged with HIV-RFP/
VSV-GorMLV-RFP/VSV-G (Figure 2D). HIV-1, but notMLV infec-
tion, was strongly impaired bymCPSF6-358. These data indicate
that the antiviral function of mCPSF6-358 is specific for a subset
of retroviruses. Similar data were obtained using HIV-1 and MLV
pseudotyped with MLV amphotropic envelope glycoprotein
(Figure S2D).
We next assayed whether other primate lentiviruses would be
susceptible to mCPSF6-358 interference. Control and mCPSF6-
358-expressing MAGI-Hi5 cells were challenged with replication-
competent HIV-1LAI, HIV-1YU-2, HIV-1JR-CSF, HIV-2ROD, SIVmac239,
orSIVmne cl.8. AnMLVvector encodingHIV-1Tat andpseudotyped
with VSV-G served as control. Although MLV-Tat/VSV-G infected
both cell populations equally, the infectivities of HIV-1, HIV-2, and
SIV were impaired approximately 10-fold or greater by mCPSF6-
358 (Figure 2E). These effects were magnified in continuous repli-
cation assays. For 3 weeks or longer culture periods, HIV-1NL4-3,
HIV-1NL4-AD8, HIV-1YU-2, and HIV-1JR-CSF did not replicate to
detectable levels in HUT-R5 cells that expressed mCPSF6-358,
although all of these viruses replicated efficiently in the parental
cells (Figure S2E).C-Terminally Truncated CPSF6 Blocks HIV-1 Trafficking
to the Nucleus
Given the role of wild-type CPSF6 in pre-mRNA processing, it
was conceivable thatmCPSF6-358 interferedwith HIV-1 expres-
sion. The presence of mCPSF6-358 in the cytoplasm could
titrate essential transcription or processing factors from the
nucleus, or low levels of the truncated protein might enter
the nucleus and interfere with gene expression. However,
mCPSF6-358 had no measurable effect on HIV-1 expression
(Figure S3A) or on the production of infectious virus (Figure S3B).
If mCPSF6-358 targeted an early replication step of HIV-1,
fewer proviruses would be generated in the presence of the anti-
viral factor. Supporting this hypothesis, 1 week after infection
with HIVNLdE-luc/VSV-G, NIH 3T3.hCycT1 cells expressing
mCPSF6-358 possessed 33-fold less vDNA than did NIH
3T3.hCycT1 cells expressing an empty control vector (Figure 3A).
This vDNA level was comparable with the 30-fold infection
reduction measured by luciferase transduction 3 days after
infection, presumably reflecting the number of integrated pro-
viruses. Because virus entry pathways appeared to be intact
in mCPSF6-358-positive cells, these data suggested that
mCPSF6-358 might interfere with reverse transcription or
integration.224 Cell Host & Microbe 7, 221–233, March 18, 2010 ª2010 ElsevierThe course of reverse transcription wasmeasured using quan-
titative PCR (qPCR) in 293T cells expressing wild-type mCPSF6
or mCPSF6-358 after infection with wild-type HIV-HSA/VSV-G
or HIVIN/D116N-HSA/VSV-G, the latter vector encoding IN with
an inactivating mutation (Figure 3B). mCPSF6-358 did not inter-
fere with the kinetics of synthesis or the overall accumulation of
early or late HIV-1 reverse transcription products. However, the
accumulation of the 2-LTR circular form of vDNA, a dead-end
form produced in the nucleus, was reduced in mCPSF6-358-ex-
pressing cells. Even infection with HIVIN/D116N-HSA/VSV-G,
which is deficient in integration and thus produces higher levels
of 2-LTR circular vDNA (Engelman et al., 1995), made far fewer
circles in cells expressing mCPSF6-358 (Figure 3B).
Our analysis of reverse transcription in mCPSF6-358-ex-
pressing cells did not distinguish whether integration-compe-
tent forms of the vDNA were synthesized but blocked from
entering the nucleus, or whether the linear vDNA was unable
to circularize or integrate. We thus examined whether functional
PICs were produced in the cytoplasm of HIV-1-infected cells
that express mCPSF6-358. PIC function in vitro requires prior
trimming of dinucleotides from both 30 ends of linear vDNA
(Chen and Engelman, 2001) and thus is a measure of functional
DNA end synthesis. As shown in Figure 3C, functional HIV-1
PICs were readily isolated from the cytoplasm of mCPSF6-
358-expressing cells. The integration efficiency was compa-
rable for PICs isolated from cells that did, or did not, express
mCPSF6-358. These data show that mCPSF6-358 does not
interfere with the completion of reverse transcription by HIV-1
and moreover suggest that mCPSF6-358 does not directly
interfere with IN function. Given the presence of functional
PICs in the cytoplasm of mCPSF6-358-expressing cells and
the absence of 2-LTR circle forms or persisting vDNA in the
same cells, we inferred that mCPSF6-358 interfered with the
nuclear entry of HIV-1 PICs.
Mutation of HIV-1 CA Confers Resistance to Truncated
CPSF6 and Alters the Infection of Nondividing Cells
We next asked whether we could select for resistance to
mCPSF6-358. Most HIV-1 isolates we tested showed no rep-
lication in HUT-R5 cells that constitutively expressed mCPSF6-
358 (Figure S2E and data not shown). An exception was
HIV-1NL4-3/BaL, which replicated to detectable levels under these
conditions (Figure 4A). HIV-1NL4-3/BaL that had been passaged
in the presence of mCPSF6-358 importantly revealed wild-
type viral replication kinetics when passed onto new HUT-
R5.mCPSF6-358 cells (Figure S4A). Sequence analysis of vDNA
isolated from cells freshly infected with the resistant stock
revealed a AAT/ GAT mutation in codon 74 of CA, causing an
N74D change in the protein. N74 and its surrounding residues
are highly conserved among known HIV-1, HIV-2, and SIV
isolates (http://www.hiv.lanl.gov/).
We tested the effect of this single substitution on the replica-
tion of HIV-1NL4-3/BaL and HIVNLdE-luc/VSV-G in cells expressing
mCPSF6-358. Similar to the uncloned resistant isolate, HIV-
1NL4-3 CA N74D/BaL was impaired neither for infection nor replica-
tion in HUT-R5.mCPSF6-358 cells (data not shown). The single-
cycle vector carrying the N74D mutation (HIVNLdE CA N74D-luc/
VSV-G) also infected cells expressing an empty vector or
mCPSF6-358 equally well, whereas the wild-type virus wasInc.
Figure 3. Analysis of HIV-1 Replication in the Presence of Truncated CPSF6
(A) Total HIV-1 DNA is reduced in NIH 3T3.hCycT1 cells expressing mCPSF6-358. (Left) Three days postinfection with HIV-luc/VSV-G, a portion of infected cells
were analyzed for luciferase activity. (Right) Seven days postinfection, DNA extracted from cells was analyzed by qPCR using gag-specific primers. vDNA copies
per microgram genomic DNA are depicted on the y axis. Error bars represent standard deviations of duplicates.
(B) qPCR measurements of HIV-1 DNA synthesis. Early (minus strand), late (plus strand), and 2-LTR circle vDNA forms are labeled on the tops of the graphs.
(C) Late reverse transcripts and PIC activity from NIH 3T3.hCycT1 cells expressing mCPSF6-358. The activity of PICs extracted from empty vector control cells
was arbitrarily set at 100%. Error bars indicate the standard errors of means derived from duplicate integration assays.
Cell Host & Microbe
CPSF6 Restricts HIV-1 Nuclear Entryrestricted about 10-fold bymCPSF6-358 (Figure 4B). These data
demonstrated that the N74D CA mutation was necessary and
sufficient for HIV-1 resistance to mCPSF6-358.Cell HoPrior experiments suggested that mCPSF6-358 interferes
with the nuclear entry of HIV-1 PICs. If true, the mCPSF6-358
block could be intensified in nonmitotic cells where HIV-1st & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevier Inc. 225
Figure 4. A Mutation in HIV-1 CA Confers Resistance to mCPSF6-
358
(A) Selection for HIV-1 resistance to mCPSF6-358.
(B) HIV-1 with the N74D mutation in CA efficiently infects nondividing HeLa
cells, and infection is not blocked in nondividing HeLa cells expressing
mCPSF6-358. Error bars represent standard deviations of duplicates.
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CPSF6 Restricts HIV-1 Nuclear EntryPICs must traverse an intact nuclear membrane to gain access
to host cell chromatin. To test this prediction, HeLa cells
expressing an empty vector or mCPSF6-358 were arrested in
the G1/S phase of the cell cycle with aphidicolin, an inhibitor
of DNA polymerase a and d. Cell-cycle arrest was verified
by FACS analysis of the aphidicolin-treated cells (data not
shown). Equal numbers of arrested and untreated HeLa cells
were challenged with MLV-luc/VSV-G and HIVNLdE-luc/VSV-G
(Figure 4B). Although MLV was insensitive to mCPSF6-358
expression, growth arrest of HeLa cells, as expected, abolished
MLV infection. In contrast, the aphidicolin-induced growth
arrest modestly impaired HIV-1 infection of HeLa cells express-
ing the empty vector, partly due to toxicity. The combination of
growth arrest and mCPSF6-358 expression potently interfered
with HIV-1 infection. The block was approximately 70-fold
relative to nondividing control cells, near the limit of sensitivity
of the assay. Growth arrest by etoposide, a less toxic inhibitor,
revealed a similar enhancement in mCPSF6-358 restriction
(Figure S4B). In nondividing cells expressing mCPSF6-358,
HIV-1 infection is no more efficient than MLV infection. By
contrast, infection by HIVNLdE CA N74D-luc/VSV-G was unaf-
fected by the combination of cell-cycle arrest and mCPSF6-
358 (Figure 4B).
CPSF6-358 Binds HIV-1 Core Complexes
The ability of the N74Dmutant to evade mCPSF6-358 restriction
suggested that the antiviral protein might directly target wild-
type CA protein. Supporting such a model, challenge of 293T
cells expressing human CPSF6-358 with increasing amounts
of virus resulted in saturation of the block such that wild-type
HIV-1 infected the restrictive cells as well as it did control cells,
or as well as N74D HIV-1 infected CPSF6-358-expressing cells
(Figure 5A). We thus tested whether pre-exposure of CPSF6-
358-expressing cells to virions with wild-type CA could abrogate226 Cell Host & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevierthe infection restriction to a second virus. CPSF6-358-express-
ing cells were first infected with increasing amounts of wild-
type and N74D HIV-1NLdE-luc. Soon after, cells were challenged
with a fixed volume of wild-type HIV-RFP. Only cells pre-
exposed to higher amounts of wild-type HIV-1NLdE-luc were
permissive to HIV-RFP infection (Figure 5B). Preinfection with
N74D HIV-1NLdE-luc did not saturate the CPSF6-358 block to
wild-type HIV-1.
These findings implied a CA-specific interaction with CPSF6-
358. We sought to test whether a physical interaction between
both proteins could be detected. As a control for such assays,
we employed another cytoplasmic form of CPSF6, the truncation
mutant CPSF6-300. Transient expression of CPSF6-300 in 293T
cells did not impair wild-type HIV-1 infection; by contrast, tran-
sient transfection of constructs expressing CPSF6-358 and
even a full-length splice variant, CPSF6(72), restricted wild-
type but not N74D HIV-1 (Figure 5C).
To assay for binding of CPSF6-358 to CA, we prepared wild-
type and N74D CA-NC complexes in vitro (Ganser et al., 1999).
The preassembled complexes were then incubated with lysates
of 293T cells transfected with CPSF6-358, CPSF6-300, or
rhTRIM5a, and these mixtures were ultracentrifuged through
a sucrose cushion. As shown previously (Stremlau et al., 2006),
wild-type CA-NC complexes pellet rhTRIM5a under these condi-
tions (Figure 5D, right panel). Interestingly, N74D CA-NC com-
plexes more efficiently precipitated rhTRIM5a (about 2-fold)
than wild-type CA-NC complexes in four separate trials (data
not shown). In comparison, CPSF6-300 purified with wild-type
and N74D CA-NC complexes at an equal efficiency (Figure 5D,
middle panel) in this and other experiments. By contrast,
CPSF6-358 copurified more efficiently with wild-type versus
N74D CA-NC cores (Figure 5D, left panel), at an average differ-
ence of 3.9-fold over four trials (data not shown).
CA Regulates the Interactions of HIV-1 PICs
with Transport and Nuclear Pore-Associated Cofactors
Having demonstrated that the N74D mutation allowed HIV-1 to
escape the mCPSF6-358 block to nuclear entry, we asked
whether any of the recently described host factors implicated
in the nuclear transport of HIV-1 PICs were CA dependent. We
depleted HeLa cells of the karyopherin, TNPO3, and the nuclear
pore-associated factor, RANBP2, by transient transfection of
siRNAs. It has been previously shown by Brass and colleagues
(Brass et al., 2008) that the knockdown of either of these proteins
impaired HIV-1 infection, and we observed similar results, most
strongly upon TNPO3 depletion (Figure 6A and Figure S5B).
Notably, TNPO3 and RANBP2 protein levels (Figures S5A and
S5C, respectively) were reduced after siRNA transfection,
although RANBP2 knockdowns were more cytotoxic to cell
cultures (data not shown). Infection with N74D HIV-1 was rela-
tively unaffected by TNPO3 or RANBP2 depletion. The observa-
tion that infection with the N74D mutant was independent of
TNPO3 suggested that this virus was transported to the nuclear
pore by a pathway different from wild-type HIV-1 and thus might
interact with different pore components.
We next treated cells with siRNAs directed against NUP85,
NUP107, NUP133, NUP153, NUP155, and NUP160, also identi-
fied as potential HIV-1 dependency factors (Brass et al., 2008).
Knockdowns of NUP85, NUP107, NUP133, NUP153, andInc.
Figure 5. CPSF6-358 Interacts with Wild-Type HIV-1 CA
(A) Different HIV-1 vectors can saturate the CPSF6-358 restriction.
(B) Preinfection with WT HIV-1 abrogates the CPSF6-358 restriction to a second virus. Error bars represent standard deviations of duplicates.
(C) CPSF6-300 does not restrict WT HIV-1. The amounts of the virus containing supernatants are shown on the x axis. Error bars represent standard deviations of
duplicates.
(D) Enhanced binding of CPSF6-358 to WT CA-NC complexes.
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Figure 6. WT and N74D HIV-1 Require Different Nuclear Pore
Factors
(A) N74D HIV-1 vectors do not require TNPO3 or RANBP2 for infection.
(B) Differential NUP requirements by WT HIV-1 and the N74D mutant.
Experiments were performed in duplicate, and statistical analysis was per-
formed by Student’s t test; *p < 0.05 and **p < 0.01 versusWT or N74DHIV-
1 infection of respective control-infected cells. Error bars represent stan-
dard deviations of four trials, each performed in duplicate.
(C) Cell growth arrest does not increase the dependence of WT HIV-1 on
TNPO3. Luciferase values reflect averages of duplicate infections with
standard deviations. The data in the right panel were from cells treated
with aphidicolin. Error bars represent standard deviations of duplicates.
(D) N74DHIV-1 is an FIV phenocopy. (Left panel) 293T cells stably express-
ing BabePuro (empty vector control), BabePuro-mCPSF6-358, or LPC-
rhTRIMa were infected with FIV-GFP(GinSin)/VSV-G (Loewen et al.,
2003). The percentage of infected cells was measured by FACS for GFP
expression; the amounts of the virus containing supernatants are shown
on the x axis. (Middle panel) HeLa.control_shRNA or HeLa.TNPO3_shRNA
cells were infected in duplicates with WT HIV-RFP/VSV-G, N74D HIV-RFP/
VSV-G, or FIV-GFP/VSV-G. Infectionwasmeasured by FACS. (Right panel)
HeLa cells transiently transfected with nontargeting and NUP-targeting
siRNA were infected in duplicates with WT HIV-RFP/VSV-G, N74D HIV-
RFP/VSV-G, or FIV-GFP/VSV-G. The average of four independent experi-
mental trials is depicted as a relative infection value. Statistical analysis
was performed by Student’s t test; *p = 0.0205, **p = 0.0009, and ***p <
0.0001 relative WT or N74D HIV-1 infection of respective control-infected
cells. Error bars represent standard deviations of four trials.
(E) E45A andQ63A/Q67AHIV-1 are TNPO3 independent. Luciferase values
reflect averages of duplicate infections with standard deviations.
(F) E45A and Q63A/Q67A HIV-1 are less sensitive to NUP depletions.
Control cell virus infections are within 10-fold of their actual activities and
were used to normalize infection values of other samples. Error bars repre-
sent standard deviations of duplicates.
(G) CPSF6-358 restriction of E45A or Q63A/Q67A HIV-1 is cell-cycle
dependent. Error bars represent standard deviations of duplicates.
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we did not have antibodies to detect NUP160 levels, siRNA
targeting of NUP160 did not significantly impair infection by
MLV (data not shown). Reductions in NUP153 or NUP160 led
to a reproducible reduction of HIV-1 infection (Figure 6B). By
contrast, N74D HIV-1 infection was more strongly diminished
in cells transfected with siRNAs for NUP85 or NUP155, and it
was also impaired in cells transfected with siRNA to NUP160.
We wanted to understand whether growth arrest would
enhance the effects of the siRNAs for nuclear pore factors on
HIV-1 infection. However, under the conditions that we
employed, the combination of the siRNAs to NUPs and the
different types of growth arrest was cytotoxic (data not shown).
By contrast, cells transfected with siRNA for TNPO3were able to
survive growth arrest.
To minimize manipulation of cells, we developed HeLa cells
stably depleted of TNPO3 (Figure S5D). The TNPO3 knockdown
cells were similar to mCPSF6-358-expressing cells in that both
types of cells were about 10-fold less susceptible to infection
by wild-type HIV-1 than were control cell lines during normal
growth (Figure 6C). As expected, infection by the N74D mutant
was essentially unimpaired by mCPSF6-358 expression or
TNPO3 depletion. When such cells were growth arrested,
a different infection pattern emerged. As shown before, nondi-
viding cells expressingmCPSF6-358 strongly restricted infection
by wild-type HIV-1, but not N74D HIV-1. By contrast, the reduc-
tion of HIV-1 infection in TNPO3-depleted cells relative to control
cells did not increase when the cells were growth arrested.
Thus, the requirement for TNPO3 in HIV-1 infection was the
same in dividing and nondividing cells. Together, these data
indicate that the karyopherin and nuclear pore requirements for
wild-type and N74D HIV-1 vary due to a single residue change
in CA, and karyopherin use by HIV-1 may be cell-cycle
independent.
Although primate lentiviruses were susceptible to mouse
and human CPSF6-358 restriction, we observed feline immuno-
deficiency virus (FIV) to be insensitive to the antiviral factor
(Figure 6D, left panel). By contrast, FIV is susceptible to
CA-mediated restriction by rhTRIM5a (Saenz et al., 2005). To
understand whether CPSF6-358 sensitivity predicted lentivirus
interactions with nuclear transport or pore proteins, we exam-
ined the infection of FIV in different knockdown cells. Similar to
N74DHIV-1, FIVwas unimpaired in the infection of cells depleted
of TNPO3 (Figure 6D, middle panel). We next tested cells
transiently depleted of NUP153, NUP155, and NUP160, factors
whose depletion more significantly affected either wild-type or
N74D HIV-1 infection. Like N74D HIV-1, depletion of NUP155
or NUP160 impaired FIV infection, whereas depletion of
NUP153 was tolerated (Figure 6D, right panel). We did not
observe effects on FIV infection of cells depleted for NUP85,
NUP107, or NUP133 (data not shown).Cell-Cycle-Dependent HIV-1 Mutants Are TNPO3
Independent and Restricted by CPSF6-358
E45A or Q63A/Q67A mutation of CA impairs HIV-1 infection of
cell-cycle-arrested cells (Yamashita et al., 2007). We thus exam-
ined whether these changes in CA could alter HIV-1 interactions
with transport factors or mCPSF6-358. Unlike wild-type HIV-1,Cell HoE45A or Q63A/Q67A HIV-1 infection was unaffected by reduced
levels of TNPO3 in stable knockdown cells (Figure 6E).
TNPO3 independence by E45A and Q63A/Q67A HIV-1 pro-
mpted further examination of their NUP requirements in siRNA-
treated cells. As in previous experiments, wild-type HIV-1
infection was more greatly diminished after transient depletion
of TNPO3,NUP153, or NUP160 (Figure 6F). N74DHIV-1 infection
was again decreased in cells depleted of NUP155 or NUP160.
Under these particular experimental conditions, NUP153 deple-
tion of HeLa cells also modestly impaired N74D HIV-1 infection.
The infection profiles of E45A and Q63A/Q67A HIV-1 were
distinct. These CA mutant viruses were typically more resistant
to the depletion of NUPs in target cells. Not only were they
TNPO3 independent, E45A and Q63A/Q67A HIV-1 were less
affected by siRNA targeting of NUP155 than was N74D HIV-1.
Thesedata collectively implied a reduceddependence of E45A
andQ63A/Q67AHIV-1on thenuclear pore for infection, or, stated
differently, an inefficient interaction by these HIV-1 mutants with
the NPC. If these viruses were less dependent on CA interactions
with pore components, then mCPSF6-358 might not interfere
with their infection. Indeed, E45A or Q63A/Q67A HIV-1 was not
restricted in dividing cells expressing mCPSF6-358 (Figure 6G).
Consistent with past reports, both E45A and Q63A/Q67A
HIV-1 were impaired approximately 30-fold and 15-fold, respec-
tively, in the infection of aphidicolin-treated control HeLa cells
(Figure 6G). Because these viruses retained the N74 residue
that appears critical for CPSF6-358 interactions, we next tested
infection interference in nondividing cells, when transport
through the nuclear pore would be required to access cellular
chromatin. In marked contrast to N74D HIV-1, mCPSF6-358
expression in the growth-arrested HeLa cells strongly restricted
infection by either E45A or Q63A/Q67A HIV-1. E45A HIV-1 infec-
tion was reduced 275-fold relative to dividing cells expressing
mCPSF6-358, and Q63A/Q67A HIV-1 infection was decreased
nearly 230-fold compared to cycling counterparts (Figure 6G).
DISCUSSION
Nondividing cells provide an important reservoir for HIV-1 infec-
tion in vivo; thus, the viral determinants and cellular factors
required for HIV-1 nuclear entry have been subjects of consider-
able interest. A mechanistic understanding of this process has
been limited by a failure to link viral regulators of nuclear entry
to host factors involved in nuclear entry. Here we have identified
an antiviral protein that restricts HIV-1 nuclear entry, selected a
CA mutant HIV-1 that overcomes this block, and shown that
CA regulates HIV-1 dependence on nuclear transport and pore
proteins.
While our study primarily focused on CPSF6-358 restriction of
HIV-1, depletion of endogenously expressed CPSF6 enhanced
HIV-1 susceptibility, and reciprocally, ectopic expression of
full-length forms of CPSF6 impaired virus infection. In vivo
expression of CPSF6 could thus restrict primate lentiviruses,
especially under circumstances where the cytoplasmic concen-
tration of the protein is elevated. The interaction of CA with the
host cell cytoplasm after entry is of interest in HIV-1 antiviral
development. TRIM5- and CPSF6-derived restrictions indicate
significant vulnerability of primate lentiviruses during these early
replication steps and suggest the feasibility of developingst & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevier Inc. 229
Figure 7. Models for HIV-1 Nuclear Entry
(A) HIV-1 nuclear entry is restricted by CPSF6-358 interaction with the CA core
(blue ovals), thus interfering with HIV-1 core disassembly or interaction with
a host transport factor (yellow polygon).
(B) HIV-1 CA regulates nuclear transport and pore protein requirements for
infection. Depletion of TNPO3, RANBP2, and NUP153 diminishes WT, but
not N74D HIV-1 infection. By contrast, depletion of NUP155 limits N74D
HIV-1 and FIV infection. Knockdown of NUP160 impaired infection by different
lentiviruses.
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provide important probes to study the replication of viruses.
With this model in mind, we have used CPSF6-358 to examine
early replication step requirements of HIV-1 and illuminated the
role of CA in regulating nuclear entry.
Expression Screen and Restriction by mCPSF6-358
Wild-type CPSF6 is a component of CF Im, a complex that
participates in the polyadenylation of pre-mRNA and is enriched
in the nucleus (Dettwiler et al., 2004; Ruegsegger et al., 1998).
We showed that a C-terminally truncated version of mCPSF6,
mCPSF6-358, which is localized in the cytoplasm, potently
restricts HIV-1 infection. HIV-2 and other SIV isolates are also
restricted by mCPSF6-358, but MLV is not. HIV-1 is restricted
in primary CD4+ T cells expressing mCPSF6-358, indicating
the pathway targeted is important in cells that are infected by
HIV-1 in patients.
The finding that human CPSF6-358 physically interacts with
wild-type HIV-1 in virus saturation experiments and with recom-
binant CA-NC complexes in precipitation assays suggests that
CPSF6-358 targets a core-associated cofactor or directly binds
to core complexes. Because there is no a priori evidence of
CPSF6 aiding HIV-1 infection, we favor the hypothesis that
CPSF6-358 interaction with incoming HIV-1 cores impairs230 Cell Host & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevierproductive interactions with uncoating or transport factors (Fig-
ure 7A). Indeed, TRIM5- or CypA-mediated restrictions can also
be enhanced in nondividing cells and have been hypothesized,
at least in the case of rhTRIM5a, to accelerate HIV-1 CA dissoci-
ation (Yamashita and Emerman, 2009).
Does CPSF6-358 target the CA directly or through an interme-
diate protein? Given that CPSF6 interacts with the polyadenyla-
tion machinery (Ruegsegger et al., 1998) and spliceosomes
(Rappsilber et al., 2002; Zhou et al., 2002) and localizes with
the nuclear paraspeckles (Dettwiler et al., 2004), the number of
potential interacting factors is large. CA interaction with a
cofactor could also explain the conservation of N74 and flanking
residues among primate lentiviruses. N74D CA has so far been
observed in one primate lentiviral isolate, SIVcpz MT145 (Keele
et al., 2006), but is otherwise rare in known HIV-1/HIV-2/SIV
isolates. Because N74D mutation of HIV-1 CA enhanced
rhTRIM5a binding, it is conceivable that TRIM5a in vivo addition-
ally counterselects an N74D core in primate lentiviruses.
Cytoplasmic CPSF6, rhTRIM5a, and TRIMCyp proteins target
HIV-1 CA through different residues, and in the case of the
latter two restriction factors provide formidable cross-species
transmission barriers. As a focal point for postentry restriction
factors, the retention of CA with the viral PIC while in the cyto-
plasm must confer a benefit during early replication. CA associ-
ated with vDNA could cloak the viral genome from host immune
sensors (Stetson et al., 2008) or could enable transport via cyto-
plasmic macromolecular machinery (McDonald et al., 2002). Our
data further suggest that CA plays an active role in the PIC inter-
action with the NPC. Understanding how CPSF6-358 physical
interaction with CA impairs interaction with the NPC is a point
of ongoing investigation.
NUP Requirements for HIV-1 Infection
The enhanced restriction of wild-type but not N74D HIV-1 by
CPSF6-358 in nondividing cells prompted further examination
of the transport and NUPs recently identified as potential HIV-1
cofactors in siRNA screens. Because both viruses are isogenic
except for a single nucleotide mutation in gag, reduced effi-
ciency of infection by one virus but not the other would strongly
suggest diminished infection was not due to cytotoxicity caused
by depletion of the protein in question.
We confirmed that wild-type HIV-1 infection was impaired by
TNPO3, RANBP2, NUP153, or NUP160 knockdown (Figure 7B).
In contrast, infection by the N74Dmutant was less dependent on
TNPO3, RANBP2, or NUP153, suggesting that these proteins
interacted, directly or indirectly, with wild-type CA during infec-
tion. The N74D mutant had an increased dependency on
NUP155. NUP85 knockdowns also appeared to diminish N74D
HIV-1 infection but to a lesser extent, whereas wild-type HIV-1
and the N74D mutant shared infection sensitivity to NUP160
depletion. Collectively, these data show that CA associated
with the RTC or PIC modulates interactions with nuclear trans-
port machinery.
A more distantly related lentivirus, FIV, behaved remarkably
similar to N74D HIV-1 in infection assays. It was not susceptible
to CPSF6-358 restriction, or sensitive to depletion of cellular
TNPO3 or NUP153. By contrast, FIV infection was impaired in
cells depleted of NUP155 or NUP160. These data indicate that
N74D HIV-1 and FIV use similar strategies to access the nucleusInc.
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the nuclear entry pathway (Figure 7B). Why distinct mechanisms
of nuclear transport are favored by HIV-1 and FIV is currently
unclear, but may reflect in vivo tissue requirements of the
viruses, or species-specific differences in cofactors or their
expression patterns.
Underscoring the pivotal role of HIV-1 CA in cytoplasmic-
nuclear trafficking, other CA mutations, E45A and Q63A/Q67A,
enable mCPSF6-358 evasion by HIV-1, but only in dividing cells.
By contrast, E45A or Q63A/Q67A HIV-1 are impaired in the infec-
tion of nondividing cells and potently restricted when these cells
express mCPSF6-358. The combined effect of cellular growth
arrest and siRNA depletion of NUPs on E45A and Q63A/Q67A
HIV-1 infection could not be evaluated due to cytotoxicity. None-
theless, in dividing cells E45A and Q63A/Q67A HIV-1 were
generally less affected by depletion of TNPO3 or NUPs relative
to wild-type and N74D HIV-1, albeit they were not as insensitive
as MLV (data not shown). Inefficient interaction with the NPC
could be why these viruses are highly susceptible to mCPSF6-
358 under growth arrest conditions. The presence of N74 in
both mutant viruses would enable CPSF6-358 binding and
further undermine an already inefficient transport through the
nuclear pore.
Consistent with our findings with HIV-1 CA mutants, we have
recently shown that HIV-1 with an MLV CA is no longer depen-
dent on TNPO3 for infection (Krishnan et al., 2010). Because
the MLV/HIV-1 chimera virus is relatively impaired for infection
and unable to infect nondividing cell types (Yamashita and Emer-
man, 2004), this study did not assess whether a loss of TNPO3
interaction was directly responsible for the impaired nuclear
entry. Experiments with N74D HIV-1 indicate that TNPO3 func-
tion is dispensable under certain conditions. Moreover, we
observed that the wild-type HIV-1 requirement for TNPO3 was
the same in dividing and nondividing cells.
The roles of other nuclear transport factors and pore proteins
in HIV-1 infection await elucidation. The mammalian NPC is
comprised of approximately 30 different proteins (Lim and Fah-
renkrog, 2006). Subunit complexes assemble into pore struc-
tures, so disruption of one component often affects another
within the same subunit. One example is that depletion of
NUP107 or NUP133, both part of the NUP107-160 subunit,
destabilizes the reciprocal molecule (Boehmer et al., 2008;
Walther et al., 2003). Although we also observed this interdepen-
dence, neither NUP107 nor NUP133 depletions, to the extent
that we achieved in viable cells, impacted virus infection. Depen-
dence on NUP155 expression correlated with resistance to
mCPSF6-358, raising the possibility that this factor directly inter-
acts with N74D HIV-1 or FIV PICs. While this type of mechanism
is tempting to consider, knockdowns of essential nuclear pore
components via siRNA are likely to be partial in surviving cells
and with a consequence of altering overall nuclear pore struc-
ture, complicating interpretation of the roles of these proteins
in wild-type andmutant virus infection. Nonetheless, if the deple-
tion of a NUP impairs HIV-1 infection, then the nuclear pore
architecture favored by the virus would appear to require the
missing cofactor. Moreover, because single amino acid changes
in CA can enable infection of nuclear pore factor knockdown
cells, it demonstrates that CA regulates HIV-1 interaction with
the nuclear pore or transport pathways.Cell HoThe mechanism of HIV-1 transport through the nuclear pore
will be further illuminated as host factor requirements are
defined. The core of herpes simplex virus type 1 is thought to
dock with the nuclear pore during infection and inject the viral
genome into the nucleus (Smith and Helenius, 2004). Intact
HIV-1 cores have also been found near nuclear pores (Arhel
et al., 2007). It is conceivable that the HIV-1 RTC/PIC undergoes
essential modifications at the nuclear pore that enables the
transfer of the vDNA into the nucleus. A recent study suggested
that HIV-1 interactions with NUPs may not be required for
nuclear entry but could affect viral integration (Ko¨nig et al.,
2008). Whether HIV-1 PICs are modified during their transit
through the nuclear membrane so that they can interact more
efficiently with cofactors in the nucleus or are coupled to these
cofactors at the nuclear pore will require additional analysis.
Given the essential role of CA in regulating HIV-1 nuclear entry,
defining the successive interactions between CA and host
factors that are necessary for this process will help to unravel
the complexities of the HIV-1 cytoplasmic-nuclear journey.
EXPERIMENTAL PROCEDURES
Expression Vectors and Reporter Viruses
The MLV vectors MIGR1, MX, and LPCX were used to generate stable cell
lines. All HIV-1 reporter vectors encoding fluorescent proteins or firefly lucif-
erase were NL4-3 derived. Reporter particles incorporated VSV-G, murine
amphotropic Env, or HIV-1 Env glycoproteins. HIV-1, HIV-2, and SIV replica-
tion-competent virus isolates, as listed in the Results, were also used in infec-
tion assays. Mouse and human CPSF6 cDNAs were purchased from Open
Biosystems, Origene, and Genecopoeia. Antibodies were purchased from
Abcam. Drs. Sabine Dettwiler and Walter Keller provided CPSF5 and CPSF6
antibodies. Dr. Ned Landau provided HIV-1NL4-3/BaL.
Viral Infections and Cell Culture
HEK293T, HeLa, MAGI, NIH 3T3.hCycT1, and TZM-bl cell lines and derivatives
were cultured in Dulbecco’s modified Eagle’s medium (Invitrogen) supple-
mented with 10% fetal bovine serum (FBS) (Hyclone). HeLa cells were growth
arrested by incubation in complete medium containing 2 mg/ml aphidicolin
(Sigma) for 24 hr and were maintained in this concentration of the drug during
the infection. Human primary CD4+ T cells were isolated from buffy coats
obtained from the New York Blood Center. Primary T cells, HUT-R5 cells,
and their derivatives were cultured in RPMI (Invitrogen) supplemented with
10% FBS. All media were supplemented with penicillin (100 U/ml) and strep-
tomycin (100 mg/ml) (Invitrogen). Primary T cells were additionally cultured in
the presence of IL-2 (50 U/ml) from R&D Systems. For viral infections, cells
were plated 1 day before infection and challenged with virus containing super-
natants in the presence of 5 mg/ml polybrene. HIV-1 CA p24 ELISA assay
(Beckman Coulter) was performed per the manufacturer’s recommendations.
Calculations of moi for GFP, HSA, or RFP encoding viruses were based on
infectious titers measured after infection of HeLa cells. Infectious titers for
luciferase or Tat-expressing vectors were determined with GHOST cells. For
transient gene silencing, siRNAs (Dharmacon) were transfected using Oligo-
fectamine (Invitrogen). Stable knockdowns were performed by transduction
with shRNA vector viruses (Sigma).
High Molecular Weight HIV-1 CA-NC Complex Binding Assay
Recombinant wild-type and N74D HIV-1 CA-NC were expressed in bacteria,
purified, and assembled in vitro as described previously for wild-type HIV-1
CA-NC (Ganser et al., 1999). Lysates containing CPSF6-358-HA, CPSF6-
300-HA, or rhTRIM5a-HA were obtained from transiently transfected 293T
cells via successive freeze/thaws in hypotonic buffer. CA-NC complexes
were mixed with cell extracts for 1 hr at room temperature before ultracentri-
fugation through a 70% sucrose cushion (Stremlau et al., 2006). HA-tagged
proteins were detected by western blotting using HRP-conjugated anti-HA,
whereas CA-NC was detected by Coomassie staining.st & Microbe 7, 221–233, March 18, 2010 ª2010 Elsevier Inc. 231
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